Market Place
Sourcing Support
Essential Announces €900M Recapitalisation via Gyrus Capital
12 Dec 2024 //
GLOBENEWSWIRE
Essential Pharma Appoints Dr. Liz Holmes As Chief Medical Officer
16 Oct 2024 //
GLOBENEWSWIRE
Essential Pharma Donates Medicines To Disaster-Hit Countries
10 Jul 2024 //
GLOBENEWSWIRE
Essential Pharma agreement with AGC Biologics for late phclinical manufacturing
11 Jun 2024 //
GLOBENEWSWIRE
Essential Pharma Signs Strategic Agreement with AGC Biologics
11 Jun 2024 //
CONTRACT PHARMA
Essential Pharma Acquires Reminyl® (galantamine) Oral Capsules
17 Apr 2024 //
GLOBENEWSWIRE
Essential completes acquisition of Renaissance its clinical stage immunotherapy
09 Apr 2024 //
PHARMABIZ
Essential & AcedrA sign Agreement to commercialize essential medicines
26 Mar 2024 //
GLOBENEWSWIRE
Essential Pharma acquires European rights to Colobreathe from Teva
08 Jan 2024 //
GLOBENEWSWIRE
Essential Pharma appoints Lee Morley as Non-Executive Director to the Board
21 Jun 2023 //
GLOBENEWSWIRE
Essential Pharma Announces the Appointment of Emma Johnson as CEO
24 May 2023 //
GLOBENEWSWIRE
UK marketing authorisations for IOPIDINE fully transferred to Essential Pharma
15 Dec 2022 //
GLOBENEWSWIRE
Essential Pharma Announces the Acquisition of HALDOL®
07 Dec 2022 //
GLOBENEWSWIRE
Essential Pharma strengthens its global operating platform
25 Aug 2022 //
PRNEWSWIRE
Essential Pharma makes strong progress in its ESG performance
19 Jul 2022 //
PRNEWSWIRE
Essential Pharma Strengthens its Global Capabilities with New Appointments
06 Apr 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.